ERIN MCNAMARA: Open Payments
NPI 1538898531 · PAOLI, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 24 payments from 15 companies in 2025. Trend: 2023 $452 · 2024 $322 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| Merz Pharmaceuticals, LLC | 3 | $93 |
| ABBVIE INC. | 3 | $57 |
| Lundbeck LLC | 2 | $52 |
| CSL Behring | 2 | $52 |
| Alexion Pharmaceuticals, Inc. | 2 | $40 |
| Amneal Pharmaceuticals LLC | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Eisai Inc. | 1 | $30 |
| PFIZER INC. | 1 | $30 |
| UCB, Inc. | 1 | $29 |
Products named: INBRIJA, VYEPTI, Hizentra, Leqembi, ULTOMIRIS, QULIPTA, Auvelity, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
